News & Articles

RNA controls can help avoid false negative results

Partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing

Digital PCR for COVID-19 wastewater testing overcomes limitations of traditional PCR

The test could be used to assess antibody response against the native spike protein of SARS-CoV-2 following COVID-19 vaccination

The company’s most significant advance in chromatography since UPLC aims to accelerate scientific research and development

This highly sensitive, cost effective assay is designed for customers who receive a high volume of food samples daily

Explore topics from oligonucleotides and high-sensitivity troponin assays to therapeutic antibodies and advances in COVID-19 sample prep

Flow Eighteen38 will provide purified proteins and data to accelerate the success of antibody projects

The 3D analysis technology provides cell cluster images and data down to individual nuclei

Dr. Santu Saha shares his team’s groundbreaking work to develop improved cancer treatments to avoid the potential side effects of chemotherapy

The company’s entire cell culture media and reagents portfolios are covered by the new certification

New capsid free antigen overcomes cross-reactivity difficulties, reducing the likelihood of false positives

Arvind Kothandaraman discusses the importance of detecting new SARS-CoV-2 variants and future trends in COVID-19 diagnostics

Explore topics from pharmaceutical kinetics and AAV characterization to oligonucleotides and high-sensitivity troponin assays